** Shares of medical technology company NXGN.O tumble
14.5% to a six-month low of $16.01; set for worst single-day
fall since June last year
** Co sees FY earnings between $0.89 to $0.95 per share
versus analyst expectations of $0.99 - Refinitiv IBES data
urn:newsml:reuters.com:*:nBw3PwdJ2a
** Brokerage Colliers, Jefferies and Piper Sandler cut their
respective price targets on the stock
** Three of eleven brokerages rate the stock "buy" or
higher, six "hold" and two "sell" or lower; their median PT is
$22
** Reports Q4 earnings at $0.21 per share, higher than
quarterly analyst expectations of $0.19
** Co has beat earnings estimates over the past six
consecutive quarters
** Up to Wednesday's close, stock had gained 2.6% so far
this year
(Reporting by Shashank Nayar in Bengaluru)
((Shashank.Nayar@thomsonreuters.com; within U.S. +1 646 223
8780; outside U.S. +91 80 6182 2256;))